0 Commentarii
0 Distribuiri
553 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Amylin Receptor Agonism and Metabolic Peptide Therapeutics Driving Market ExpansionSurging global prevalence of Type 2 diabetes mellitus, expanding clinical focus on combination anti-obesity therapeutics, and accelerating research into amyloid aggregation inhibition are driving strategic interest in the global Islet Amyloid Polypeptide Market. Islet Amyloid Polypeptide (IAPP, or Amylin) is a pancreatic peptide co-secreted with insulin that regulates postprandial glucose...0 Commentarii 0 Distribuiri 230 Views 0 previzualizare
-
Could Precision Medicine Accelerate Innovation in the Peptide-Drug Conjugate Therapeutics Market?According to the latest report published by Data Bridge Market Research, the Peptide-Drug Conjugate Therapeutics Market CAGR Value The global peptide-drug conjugate therapeutics market size was valued at USD 1.46 billion in 2025 and is expected to reach USD 7.07 billion by 2033, at a CAGR of 21.80% during the forecast period Peptide-Drug Conjugate Therapeutics Market report...0 Commentarii 0 Distribuiri 753 Views 0 previzualizare
-
Global Peptide Therapeutics Drugs Market: Trends, Drivers, and Future OutlookThe Peptide Therapeutics Drugs Market is experiencing significant growth, driven by the increasing demand for targeted and personalized therapies. Valued at USD 35.1 billion in 2024, the market is projected to reach USD 60.0 billion by 2035, registering a CAGR of 5.0%. This expansion is fueled by the rising prevalence of chronic diseases, technological breakthroughs in peptide...0 Commentarii 0 Distribuiri 513 Views 0 previzualizare
-
Novel Antibacterial Agents: The Future of Antimicrobial Peptide TherapeuticsThe development of novel antibacterial agents has become a global health priority, with antimicrobial peptides emerging as a promising class of therapeutics. Novel antibacterial agents are urgently needed to address the growing threat of antimicrobial resistance and ensure continued effectiveness against bacterial infections. The anti-microbial peptides market is experiencing...0 Commentarii 0 Distribuiri 465 Views 0 previzualizare
-
Peptide Therapeutics Market Set for USD 444.1 Billion Valuation by 2036, India - CAGR 11.6%, China - CAGR 10.9%, USA - CAGR 10.2%The global peptide therapeutics market is estimated at USD 156.4 billion in 2026 and is projected to reach USD 444.1 billion by 2036, expanding at an 11.0% CAGR during the forecast period. Fact.MR estimates an absolute dollar opportunity of USD 287.7 billion between 2026 and 2036, as the commercial success of peptide-based treatments for metabolic disorders combines with expanding clinical...0 Commentarii 0 Distribuiri 414 Views 0 previzualizare
-
Peptide Therapeutics Market: Five Signals That Growth Will Stay Strong Through 2033How large can a drug class get once it proves it can treat obesity, diabetes and heart risk at the same time? The peptide therapeutics market offers an early answer. Valued at USD 140.9 billion in 2025, it is projected to reach USD 294.6 billion by 2033, growing at 8.7% annually from 2026. North America accounts for 61.9% of today’s revenue, but the factors that decide the next USD 130...0 Commentarii 0 Distribuiri 786 Views 0 previzualizare
-
Protein and Peptide Therapeutics Market Trends, Technologies, and Key Players AnalysisThe Protein and Peptide Therapeutics Market is a dynamic and vital sector within the global biopharmaceutical industry, playing an increasingly central role in treating complex diseases. With a market value of USD 40.6 Billion in 2025 and projections to reach USD 59.8 Billion by 2035 at a steady CAGR of 4.0%, this sector is undergoing a significant transformation driven by scientific...0 Commentarii 0 Distribuiri 829 Views 0 previzualizare
-
U.S. Peptide Therapeutics Market Economic Environmental Analysis and Future Forecast 2033The U.S. peptide therapeutics retail market is experiencing strong growth as peptide-based medicines become increasingly important in the treatment of diabetes, obesity, weight management, hormone-related conditions, and other chronic diseases. Growing use of GLP-1 receptor agonists, expanding patient awareness, and increasing availability through retail pharmacies and telehealth platforms are...0 Commentarii 0 Distribuiri 416 Views 0 previzualizare